Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis

Ocular Immunology and Inflammation

Volumn 14, Issue 4, 2006, Pages 233-238

  Özkiris, Abdullah ^a,b  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b Yildirim Beyazit Mah Mustafa Simsek   (Turkey)

Author keywords

Intravitreal triamcinolone acetonide; Posterior uveitis; Systemic corticosteroid

Indexed keywords

CORTICOSTEROID; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG EFFICACY; EYE INFLAMMATION; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SCORING SYSTEM; SYSTEMIC THERAPY; UVEITIS; VISUAL ACUITY;

ACUTE DISEASE; ADULT; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; UVEITIS, POSTERIOR; VISUAL ACUITY; VITREOUS BODY;

EID: 33747603505     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940600826604     Document Type: Article

References (29)

1. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:332-336.
2. Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, Nussenblatt RB, Stiehm ER, Tessler H, Van Gelder RN, Whitcup SM, Yocum D. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492-513.
3. Erkilic K, Evereklioglu C, Cekmen M, Ozkiris A, Duygulu F, Dogan H. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behcet's disease: original contributions/clinical and laboratory investigations. Mediators Inflamm. 2003;12(2):107-116.
4. Tanner V, Kanski JJ, Frith PA. Posterior sub-Tenon's triamcinolone injections in the treatment of uveitis. Eye. 1998;12:679-685.
5. Yoshikawa K, Kotake S, Ichiishi A, Sasamoto Y, Kosaka S, Matsuda H. Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol. 1995;39:71-76.
6. Moshfeghi DM, Lowder CY, Roth DB, Kaiser PK. Retinal and choroidal vascular occlusion after posterior sub-Tenon triamcinolone injection. Am J Ophthalmol. 2002;134:132-134.
7. Modarres M, Parvaresh MM, Peyman GA. Accidental subretinal injection of triamcinolone acetonide. Ophthalmic Surg Lasers. 1998;29:935-938.
8. Ozkiris A, Evereklioglu C, Oner A, Erkilic K. Pattern electroretinogram for monitoring the efficacy of intravitreal triamcinolone injection in diabetic macular edema. Doc Ophthalmol. 2004;109:139-145.
9. Ozkiris A, Evereklioglu C, Erkilic K, Dogan H. Intravitreal triamcinolone acetonide for treatment of persistent macular edema in branch retinal vein occlusion. Eye. 2006;20:13-17.
10. Ozkiris A, Evereklioglu C, Erkilic K, Ilhan O. The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion. Eur J Ophthalmol. 2005;15:96-101.
11. Ozkiris A, Evereklioglu C, Erkilic K, Tamcelik N, Mirza E. Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema. Eur J Ophthalmol. 2004;14:543-549.
12. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol. 2003;136:384-386.
13. Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92:467-471.
14. Holladay JT. Proper method for calculating average visual acuity. J Refr Surg. 1997;13:388-391.
15. Toker E, Kazokoglu H, Acar N. High dose intravenous steroid therapy for severe posterior segment uveitis in Behcet's disease. Br J Ophthalmol. 2002;86:521-523.
16. Mahlberg K, Uusitalo H, Uusitalo R, Palkama A, Tallberg T. Suppression of experimental autoimmune uveitis in guinea pigs by ethylenediamine tetra-acetic acid, corticosteroids, and cyclosporin. J Ocul Pharmacol. 1987;3:199-210.
17. Floman N, Zor U. Mechanism of steroid action in ocular inflammation: inhibition of prostaglandin production. Invest Ophthalmol Vis Sci. 1977;16:69-73.
18. Nussenblatt RB. Uveitis in Behcet's disease. Int Rev Immunol. 1997;14:67-79.
19. Jones NP, Anderton LC, Cheong FM, Whallett A, Stanford MR, Murray PI, Lesnik-Oberstein S, Pavesio C. Corticosteroid-induced osteoporosis in patients with uveitis. Eye. 2002;16:587-593.
20. Auer C, Tran VT, Guex-Crosier Y, Pittet N, Herbort CP. Indications and complications of systemic corticosteroid therapy in treatment of uveitis. Klin Monatsbl Augenheilkd. 1994;204:337-339.
21. Scholes GN, O'Brien WJ, Abrams GW, Kubicek MF. Clearance of triamcinolone from vitreous. Arch Ophthalmol. 1985;103:1567-1569.
22. Okada AA, Wakabayashi T, Morimura Y, Kawahara S, Kojima E, Asano Y, Hida T. Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis. Br J Ophthalmol. 2003;87:968-971.
23. Helm CJ, Holland GN. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol. 1995;120:55-64.
24. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Fytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology. 2001;108:765-772.
25. Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol. 2001;29:2-6.
26. Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol. 2001;119:1380-1383.
27. Ozkiris A, Erkilic K. The complications of intravitreal triamcinolone acetonide injection. Can J Ophthalmol. 2005;40:63-68.
28. Nussenblatt RB, Palestine AG, Chan CC. Cyclosporin. A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol. 1983;96:275-282.
29. Dugel PU, Rao NA, Ozler S, Liggett PE, Smith RE. Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. A preliminary study. Ophthalmology. 1992;99:1535-1541.